PubMed ID:
35372821
Public Release Type:
Journal
Publication Year: 2022
DOI:
https://doi.org/10.1016/j.xkme.2022.100442
Authors:
Damron Kelli Collins, Friedman Robert, Inker Lesley A., Thompson Aliza, Grams Morgan E., Guðmundsdóttir Hrefna, Willis Kerry, Manley Tom, Heerspink Hiddo L., Weiner Daniel E.
Request IDs:
20522
,
20733
Studies:
African American Study of Kidney Disease and Hypertension Study (Clinical Trial)
With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patients’ understanding of these, as well as incorporating patient preferences and tolerance for side effects into shared decision making.